COMMUNICATION
Helicobacter pylori Generates Superoxide Radicals and Modulates Nitric Oxide Metabolism*

Kumiko NagataDagger , Hidenori Yu§, Manabu Nishikawa§, Misato Kashiba§, Akihiro Nakamura§, Eisuke F. Sato§, Toshihide TamuraDagger , and Masayasu Inoue§

From the Dagger  Department of Bacteriology, Hyogo College of Medicine, 1-1 Mukogawa, Nishinomiya, Hyogo 663 and § Department of Biochemistry, Osaka City University Medical School, 1-4-54 Asahimachi, Abeno, Osaka 545, Japan

    ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results & Discussion
References

During studies of the bactericidal action of nitric oxide (NO), we found that it reversibly inhibited the respiration of Escherichia coli and irreversibly inhibited the respiration of Helicobacter pylori. Peroxynitrite, a reaction product of NO and superoxide, irreversibly inhibited the respiration of both H. pylori and E. coli. H. pylori, but not E. coli, generated substantial amounts of superoxide radicals. These results suggest that NO directly inhibits the respiration of E. coli whereas it rapidly reacts with endogenously generated superoxide radicals in H. pylori. The resulting peroxynitrite inactivates the respiration of H. pylori.

    INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results & Discussion
References

Nitric oxide (NO)1 is a multifunctional gaseous free radical produced by NO synthase in various types of cells, such as endothelial cells, neurons, neutrophils, and macrophages (1). Nitric oxide is also generated from nitrite in saliva and from food by microorganisms in the oral cavity as well as by nonenzymatic mechanisms under acidic conditions, such as in gastric juice (12). Because NO synthase is also present in gastric mucosa (13, 14), physiological concentrations of NO in gastric juice are fairly high.

We have shown that the biological activity of NO is augmented significantly by physiologically low levels of oxygen tension (2-5). Although NO plays important roles in defense mechanisms against enteric bacteria (6, 7), few studies have explored the mechanism of its bactericidal action at physiological levels of oxygen tension.

Helicobacter pylori is a Gram-negative and microaerophilic bacterium that resides in the mucus layer overlying the gastric epithelium of the human stomach. This organism is thought to play essential roles in the pathogenesis of gastric inflammation, ulceration, and carcinogenesis (8-11). Although H. pylori is exposed to fairly high concentrations of NO in gastric juice, which has low oxygen tension, the effect of NO on the metabolism of H. pylori remains to be defined. We therefore studied the effects of NO on the respiration of H. pylori and Escherichia coli under physiologically low levels of oxygen tension.

    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results & Discussion
References

Reagents-- Peroxynitrite solution and carboxy-2-phenyl-4,4,5,5-tetramethylimidazolin-1-oxyl-3-oxide (cPTIO) were obtained from Dojin Co. (Kumamoto, Japan). Mn-type superoxide dismutase (SOD) from E. coli and 2-methyl-6-[p-methoxyphenyl]-3,7-dihydroimidazol[1,2-alpha ]pyra zin-3-one (MCLA) were obtained from Sigma and Tokyo Kasei Kogyo Co. (Tokyo, Japan), respectively. Nitric oxide solution was prepared as described previously (5).

Bacterial Strains and Their Culture-- Two types of enteric bacteria, E. coli K-12 JM109 and H. pylori NCTC-11637, were used in all experiments. E. coli was cultured at 37 °C with shaking in nutrient broth (Difco) containing 0.5% NaCl. H. pylori was cultured in Brucella broth containing 5% horse serum under a microaerophilic atmosphere, produced with the use of a gas pack BBL CampyPak (Becton, MD), at 37 °C for 20 h as described previously (15). The cultured E. coli and H. pylori were harvested at the logarithmic growth phase, suspended in 10 mM HEPES buffer (pH 7.0) containing 0.9% NaCl, and used in the experiments.

Analysis of Bacterial Respiration-- Respiration of E. coli and H. pylori was monitored polarographically at 37 °C in 10 mM HEPES buffer (pH 7.0) containing 0.9% NaCl and 5 mM succinate. A Clark-type oxygen electrode was used as described previously (5).

Assay of Superoxide and SOD Activity-- Superoxide was determined by the cytochrome c method (16) and the chemiluminescence method (17) with the use of a Bio-Orbit 1251 luminometer in buffer solution containing 1 µM MCLA and 0.5% Triton X-100. After disrupting cells by sonication, the samples were centrifuged at 10,000 × g and 4 °C for 20 min. SOD activity in the supernatant was determined spectrophotometrically with an SOD assay kit (Calbiochem). The assay is based on the SOD-mediated increase in the rate of autooxidation of 5,6,6a,11b-tetrahydro-3,9,10-trihydroxybenzo[c]fluorene in aqueous alkaline solution (18). Protein concentrations in the samples were determined by the method of Lowry et al. (19).

    RESULTS AND DISCUSSION
Top
Abstract
Introduction
Materials & Methods
Results & Discussion
References

Fig. 1 shows the succinate-dependent respiration of E. coli and H. pylori. Nitric oxide reversibly inhibited the respiration of E. coli. Consistent with our previous observations with mitochondria (2-4) and E. coli (5), the inhibitory effect of NO increased with a decrease in oxygen concentration of the medium. Although NO also inhibited the respiration of H. pylori in an oxygen concentration-dependent manner, it was significantly less active than with E. coli, and inhibition persisted throughout the observation period. Washing the NO-treated cells did not restore respiratory activity of H. pylori (data not shown).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 1.   Inhibition of cellular respiration by NO. Respiration of E. coli and H. pylori (1 × 108 cells/ml) was monitored polarographically with a Clark-type oxygen electrode at 37 °C in 10 mM HEPES-NaOH (pH 7.0) containing 0.9% NaCl and 5 mM succinate. At the indicated times (arrows), NO was added to give a final concentration of 5 µM. Dotted lines, control experiments without NO.

Because NO is rapidly metabolized into various compounds, such as nitrite and nitrate, these metabolite(s) might act to inhibit cellular respiration. To test this hypothesis, we studied the effects of NO metabolites and NO-trapping agents on respiration. Fairly high concentrations of nitrite and nitrate (~100 µM) did not inhibit the respiration of E. coli or H. pylori (Fig. 2). In contrast, both cPTIO and oxyhemoglobin, NO-trapping agents (20, 21), instantaneously abolished the inhibitory effect of NO on the respiration of E. coli. Thus, NO, rather than its metabolites, might directly interact with E. coli and thereby inhibit cellular respiration. In the case of H. pylori, neither cPTIO nor oxyhemoglobin abolished the inhibitory effect of NO. Thus, some metabolite(s) of NO other than nitrite and nitrate might irreversibly inhibit the respiration of H. pylori.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 2.   Effects of NO and related compounds on respiration. At the indicated times, either nitrite (NO2-), nitrate (NO3-), NO, or peroxynitrite (ONOO-) was added to reaction mixtures containing E. coli or H. pylori. In the presence of 5 (E. coli) or 35 µM (H. pylori) of NO, either red blood cells (RBC) or cPTIO was added to the reaction mixture (arrows). The final concentrations of cPTIO were 10 and 40 µM for experiments with E. coli and H. pylori, respectively. Other conditions were as described for Fig. 1. Dotted line, control experiments; line 1, +100 µM NO2-; line 2, +100 µM NO3-; line 3, +NO; line 4, NO + cPTIO; line 5, NO + red blood cells (0.1% hematocrit); line 6, 10 (for E. coli) or 45 µM (for H. pylori) ONOO-.

Because NO rapidly reacts with superoxide radicals (k = 6.9 × 109 M-1 s-1) and generates cytotoxic peroxynitrite, effects of this metabolite on the respiration of E. coli and H. pylori were tested. When added to the incubation mixture, peroxynitrite inhibited the respiration of both organisms (Fig. 2). The characteristics of inhibition by peroxynitrite were similar to those of inhibition of H. pylori by NO. Inhibited respiration of both organisms persisted even after washing the cells with incubation medium (data not shown). Thus, peroxynitrite rather than NO and other metabolites might cause the irreversible inhibition of the respiration of H. pylori. These observations suggest that H. pylori might generate superoxide radicals that rapidly react with NO and generate peroxynitrite.

To test this hypothesis, the rate of superoxide generation and cellular levels of SOD were compared between the two organisms. When incubated in a medium containing MCLA, a chemiluminescence probe, H. pylori, elicited marked chemiluminescence that peaked after 2-3 min of incubation (Fig. 3). The MCLA chemiluminescence was strongly inhibited by Mn-SOD, suggesting the involvement of superoxide radicals. Under identical conditions, MCLA chemiluminescence was negligible with E. coli. In contrast to the superoxide generating activity, the cellular level of SOD was significantly lower in H. pylori than in E. coli (Table I). Based on the chemiluminescence intensity of MCLA, the steady-state level of superoxide generated by H. pylori was calculated to be 21 ± 9 µM. Because this superoxide concentration approximates that of NO used in the present experiments, NO might be rapidly trapped by superoxide radicals in and around H. pylori, forming peroxynitrite. Because peroxynitrite is cytotoxic, this metabolite, rather than NO, might irreversibly inhibit the respiration of H. pylori. Consistent with this notion is the finding that peroxynitrite, similar to NO, irreversibly inhibited the respiration of H. pylori.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 3.   Superoxide generation by H. pylori. Incubation mixtures contained in a final volume of 1 ml, 1 µM MCLA, 0.5% Triton X-100, and 1 × 108 cells/ml of either E. coli (squares) or H. pylori (circles). Chemiluminescence intensity was monitored continuously in the presence (closed circles) or absence (open symbols) of Mn-SOD (100 units/ml). Other conditions were as described for Fig. 1. Each point represents the mean value derived from two experiments.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Superoxide generation and SOD activity in E. coli and H. pylori
Superoxide was determined by the chemiluminescence method (17) using a Bio-Orbit 1251 luminometer in buffer solution containing 1 µM MCLA and 0.5% Triton X-100. After disrupting cells by sonication, the homogenates were centrifuged at 10,000 × g and 4 °C for 20 min. SOD activity in the supernatants was determined with an SOD assay kit. SOD-sensitive chemiluminescence intensity of 106 cpm corresponds to the formation of 0.6 µM superoxide per min, as determined by the cytochrome c method (16). Protein concentrations of 108 cells/ml corresponded to 300 and 200 µg/ml for E. coli and H. pylori, respectively.

Because peroxynitrite reacts with metals and Fe-S clusters in various proteins and oxidizes sulfhydryl groups of proteins (22-26), it might affect some component(s) in the respiratory systems of bacteria. The highly toxic nature of peroxynitrite and its metabolites (hydroxyl radical) may also impair the structure and functions of cell constituents, including proteins and DNA. Preliminary experiments using anti-nitrotyrosine antibody and Western blotting after sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed significant amounts of immunoreactive protein bands in NO-treated H. pylori but not in NO-treated E. coli. Helicobacter species show considerable genomic variation (27, 28). This genomic diversity may be one reason for their success as ubiquitous pathogens. Preliminary polymerase chain reaction-based RFLP analysis of the gene encoding urease showed that NO induced mutation in H. pylori. Under identical conditions, NO had no appreciable effect on DNA samples obtained from NO-treated E. coli. These observations are consistent with the hypothesis that NO reacted with endogenously generated superoxide radicals and the resulting peroxynitrite reacted with proteins and DNA of H. pylori. Reactive oxygen species, including peroxynitrite and hydroxyl radicals, have been well documented to induce gene mutations and cancer. Thus, generation of superoxide and related metabolites might underlie the mechanisms of their genetic diversity and their role in the pathogenesis of gastric inflammation and cancer (29-33). However, these possibilities require further investigation before firm conclusions can be made.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed. Tel. and Fax: 81-6-645-2025; E-mail: masainoue{at}msic.med.osaka-cu.ac.jp.

1 The abbreviations used are: NO, nitric oxide; cPTIO, carboxy-2-phenyl-4,4,5,5-tetramethylimidazolin-1-oxyl-3-oxide; SOD, superoxide dismutase; MCLA, 2-methyl-6-[p-methoxyphenyl]-3,7-dihydroimidazol[1,2-alpha ]pyrazin-3-one.

    REFERENCES
Top
Abstract
Introduction
Materials & Methods
Results & Discussion
References

  1. Nathan, C., and Xie, Q. (1994) Cell 78, 915-918[Medline] [Order article via Infotrieve]
  2. Tekehara, Y., Kanno, T., Yoshioka, T., Inoue, M., and Utsumi, K. (1995) Arch. Biochem. Biophys. 323, 27-32[CrossRef][Medline] [Order article via Infotrieve]
  3. Inai, Y., Takehara, Y., Yabuki, M., Sato, E. F., Akiyama, J., Inoue, M., Horton, A. A., and Utsumi, K. (1996) Cell Struct. Funct. 21, 151-157[Medline] [Order article via Infotrieve]
  4. Nishikawa, M., Sato, E. F., Utsumi, K., and Inoue, M. (1996) Cancer Res. 56, 4535-4540[Abstract]
  5. Yu, H., Sato, E. F., Nagata, K., Nishikawa, M., Kashiba, M., Arakawa, T., Kobayashi, K., Tamura, T., and Inoue, M. (1997) FEBS Lett. 409, 161-165[CrossRef][Medline] [Order article via Infotrieve]
  6. Lin, J. Y., and Chadee, K. (1992) J. Immunol. 148, 3999-4005[Abstract/Free Full Text]
  7. Beckerman, K. P., Rogers, H. W., and Corbett, J. A. (1993) J. Immunol. 150, 888-895[Abstract/Free Full Text]
  8. Blaser, M. J. (1990) J. Infect. Dis. 161, 626-633[Medline] [Order article via Infotrieve]
  9. Parsonnet, J., Friedman, G. D., Vandersteen, D. P., Chang, Y., Vogelman, J. H., Orentreich, N., and Sibley, R. K. (1991) N. Engl. J. Med. 325, 1127-1131[Abstract]
  10. Parsonnet, J., Hansen, S., Rodriguez, L., Gelb, A. B., Warnke, R. A., Jellum, E., Orentrich, N., Vogelman, J. H., and Friedman, G. D. (1994) N. Engl. J. Med. 330, 1267-1271[Abstract/Free Full Text]
  11. Rabeneck, L., and Ransohoff, D. F. (1991) Am. J. Med. 91, 566-572[Medline] [Order article via Infotrieve]
  12. Lundberg, J. O. N., Weitzberg, E., Lundberg, J. M., and Alving, K. (1994) Gut 35, 1543-1546[Abstract]
  13. Brown, J. F., Tepperman, B. L., Hanson, P. J., Whittle, B. J. R., and Moncada, S. (1992) Biochem. Biophys. Res. Commun. 184, 680-685[Medline] [Order article via Infotrieve]
  14. Akiba, Y., Nakamura, M., Ito, T., Morikawa, A., Oda, M., and Tsuchiya, M. (1993) Gastroenterology 104, (suppl.) A31
  15. Nagata, K., Satoh, H., Iwahi, T., Shimoyama, T., and Tamura, T. (1993) Antimicrob. Agents Chemother. 37, 769-774[Abstract]
  16. McCord, J., and Fridovich, I. (1969) J. Biol. Chem. 244, 6049-6055[Abstract/Free Full Text]
  17. Nakano, M., Sugioka, K., Ushijima, Y., and Goto, T. (1986) Anal. Biochem. 159, 363-369[Medline] [Order article via Infotrieve]
  18. Nebot, C., Moutet, M., Huet, P., Xu, J. Z., Yadan, J. C., and Chaudiere, J. (1993) Anal. Biochem. 214, 442-451[CrossRef][Medline] [Order article via Infotrieve]
  19. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951) J. Biol. Chem. 193, 265-275[Free Full Text]
  20. Akaike, T., Yoshida, M., Miyamoto, Y., Sato, K., Kohno, M., Sasamoto, K., Miyazaki, K., Ueda, S., and Maeda, H. (1993) Biochemistry 32, 827-832[Medline] [Order article via Infotrieve]
  21. Doyle, M. P., and Hoekstra, J. W. (1981) J. Inorg. Biochem. 14, 351-358[CrossRef][Medline] [Order article via Infotrieve]
  22. Mayer, J. (1981) Arch. Biochem. Biophys. 210, 246-256[Medline] [Order article via Infotrieve]
  23. Granger, D. L., and Lehninger, A. L. (1982) J. Cell Biol. 95, 527-535[Abstract]
  24. Reddy, D., Lancaster, J. R., and Cornforth, D. P. (1983) Science 221, 769-770[Medline] [Order article via Infotrieve]
  25. Drapier, J. C., and Hibbs, J. B., Jr. (1986) J. Clin. Invest. 78, 690-797
  26. Radi, R., Rodriguez, M., Castro, J., and Telleri, R. (1994) Arch. Biochem. Biophys. 308, 89-95[CrossRef][Medline] [Order article via Infotrieve]
  27. Jorgensen, M., Daskalopoulos, G., Warburton, V., Mitchell, H. M., and Hazell, S. L. (1996) J. Infect. Dis. 174, 631-635[Medline] [Order article via Infotrieve]
  28. Blaser, M. J. (1996) in Genetic Basis for Heterogeneity of Helicobacter pylori: Helicobacter pylori Basic Mechanisms to Clinical Cure (Hunt, R. H., and Tygat, G. N. J., eds), pp. 33-39, Kluwer Academic Publishers, Dordrecht, The Netherlands
  29. Perchellet, J. P., and Perchellet, E. M. (1989) Free Radical Biol. Med. 7, 377-408[CrossRef][Medline] [Order article via Infotrieve]
  30. Basu, A. K., Lechler, E. L., Leadon, S. A., and Essigmann, J. M. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 7677-7681[Abstract]
  31. Salgo, M. G., Stone, K., Squadrito, G. L., and Pryor, W. A. (1995) Biochem. Biophys. Res. Commun. 210, 1025-1030[CrossRef][Medline] [Order article via Infotrieve]
  32. Yermilov, V., Rubio, J., and Oshima, H. (1995) FEBS Lett. 376, 207-210[CrossRef][Medline] [Order article via Infotrieve]
  33. Lie, J. L., Okada, S., Hamazaki, S., Ebina, Y., and Midorikawa, O. (1987) Cancer Res. 47, 1867-1869[Abstract]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.